Besse B - Search Results

1

Molecular mechanisms of resistance to BRAF and MEK inhibitors in BRAF^V600E non-small cell lung cancer.

Facchinetti F, Lacroix L, Mezquita L, Scoazec JY, Loriot Y, Tselikas L, Gazzah A, Rouleau E, Adam J, Michiels S, Massard C, André F, Olaussen KA, Vassal G, Howarth K, Besse B, Soria JC, Friboulet L, Planchard D. Facchinetti F, et al. Among authors: besse b. Eur J Cancer. 2020 Jun;132:211-223. doi: 10.1016/j.ejca.2020.03.025. Epub 2020 May 6. Eur J Cancer. 2020. PMID: 32388065

2

Nuclear localization of apoptosis protease activating factor-1 predicts survival after tumor resection in early-stage non-small cell lung cancer.

Besse B, Candé C, Spano JP, Martin A, Khayat D, Le Chevalier T, Tursz T, Sabatier L, Soria JC, Kroemer G. Besse B, et al. Clin Cancer Res. 2004 Sep 1;10(17):5665-9. doi: 10.1158/1078-0432.CCR-04-0415. Clin Cancer Res. 2004. PMID: 15355891

3

[Predicting response to Iressa: unexpected mechanism].

Besse B, Le Chevalier T, Soria JC. Besse B, et al. Med Sci (Paris). 2004 Aug-Sep;20(8-9):750-1. doi: 10.1051/medsci/2004208-9750. Med Sci (Paris). 2004. PMID: 15361339 Free article. French. No abstract available.

4

Epidermal growth factor receptor, HER-2/neu and related pathways in lung adenocarcinomas with bronchioloalveolar features.

Erman M, Grunenwald D, Penault-Llorca F, Grenier J, Besse B, Validire P, Morat L, Girard P, Le Chevalier T, Sabatier L, Soria JC. Erman M, et al. Among authors: besse b. Lung Cancer. 2005 Mar;47(3):315-23. doi: 10.1016/j.lungcan.2004.08.015. Lung Cancer. 2005. PMID: 15713515

5

[EGFR-targeted therapies: what's new?].

Vignot S, Besse B, Soria JC, Milano G, Spano JP. Vignot S, et al. Among authors: besse b. Bull Cancer. 2006 Jan;93(1):13-8. Bull Cancer. 2006. PMID: 16455501 Free article. Review. French.

6

[Cannabis and cancer].

Vignot S, Besse B, de la Motte Rouge T, Massard C, Spano JP, Karila L. Vignot S, et al. Among authors: besse b. Bull Cancer. 2006 Feb;93(2):163-70. Bull Cancer. 2006. PMID: 16517414 Free article. Review. French.

7

[Neoadjuvant chemotherapy in non small cell lung cancer].

Besse B, Vignot S, Le Chevalier T. Besse B, et al. Bull Cancer. 2006 Nov;93(11):1087-92. Bull Cancer. 2006. PMID: 17145577 Free article. Review. French.

8

Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast.

Grenier J, Soria JC, Mathieu MC, Andre F, Abdelmoula S, Velasco V, Morat L, Besse B, Dunant A, Spielmann M, Delaloge S. Grenier J, et al. Among authors: besse b. Anticancer Res. 2007 Jan-Feb;27(1B):547-55. Anticancer Res. 2007. PMID: 17348440 Free article.

9

[Treatment of cancer: surgery, radiotherapy, chemotherapy, hormonal therapy. Multidisciplinary therapeutic decision making and informing the patient].

Besse B, Soria JC. Besse B, et al. Rev Prat. 2007 Feb 28;57(4):429-40; quiz 440. Rev Prat. 2007. PMID: 17455746 Review. French. No abstract available.

10

Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer.

Saintigny P, Besse B, Callard P, Vergnaud AC, Czernichow S, Colombat M, Girard P, Validire P, Breau JL, Bernaudin JF, Soria JC. Saintigny P, et al. Among authors: besse b. Clin Cancer Res. 2007 Aug 15;13(16):4825-31. doi: 10.1158/1078-0432.CCR-06-3061. Clin Cancer Res. 2007. PMID: 17699861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

615 results

Search Page

Filters